HCA Healthcare, Inc. $HCA Shares Sold by ANTIPODES PARTNERS Ltd

ANTIPODES PARTNERS Ltd lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.5% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 362,179 shares of the company’s stock after selling 29,279 shares during the period. HCA Healthcare comprises about 3.5% of ANTIPODES PARTNERS Ltd’s investment portfolio, making the stock its 6th biggest holding. ANTIPODES PARTNERS Ltd owned 0.16% of HCA Healthcare worth $154,372,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently bought and sold shares of HCA. Cerity Partners LLC grew its position in shares of HCA Healthcare by 13.1% during the 3rd quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after buying an additional 5,092 shares during the period. Swiss National Bank boosted its stake in HCA Healthcare by 4.3% in the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after purchasing an additional 23,100 shares during the period. Savant Capital LLC lifted its stake in HCA Healthcare by 37.7% in the 3rd quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock valued at $1,938,000 after acquiring an additional 1,246 shares in the last quarter. Sector Gamma AS increased its position in shares of HCA Healthcare by 36.0% in the third quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock valued at $4,638,000 after acquiring an additional 2,883 shares during the last quarter. Finally, National Pension Service grew its position in shares of HCA Healthcare by 2.9% in the 3rd quarter. National Pension Service now owns 626,585 shares of the company’s stock valued at $267,051,000 after acquiring an additional 17,531 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently commented on HCA shares. Raymond James Financial set a $525.00 target price on shares of HCA Healthcare in a report on Monday, October 27th. Truist Financial boosted their price objective on shares of HCA Healthcare from $520.00 to $546.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. UBS Group raised their price target on shares of HCA Healthcare from $525.00 to $598.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Bank of America upped their price target on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a report on Monday, October 27th. Finally, Leerink Partners upped their target price on HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a report on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $530.77.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA is expanding emergency access through local partnerships and new freestanding ERs, which can increase lower‑acuity, higher‑margin volumes and outpatient revenue. Read More.
• Positive Sentiment: HCA opened a new ER site (Shoppes at Mission Trace) — incremental access points support ambulatory/ER growth. Read More.
• Positive Sentiment: Analyst and momentum coverage is favorable: Zacks highlights HCA as a momentum name and JPMorgan raised its price target to $535 (neutral rating but higher target), both of which can attract investor flows. Read More. — Read More.
• Neutral Sentiment: Local human‑interest/community health stories (neonatal success, suicide‑prevention grant) are positive for brand but unlikely to move the stock materially. Read More. — Read More.
• Neutral Sentiment: Leadership moves (new chief nurse in Houston; four new leaders in Alaska) are operational/clinic-level changes that support execution but are not major catalysts on their own. Read More. — Read More.
• Negative Sentiment: A nurse sued HCA Florida Palms West Hospital and a security company after a violent patient attack — litigation and safety concerns can raise reputational risk and potential costs. Read More.
• Negative Sentiment: Critical opinion pieces highlight continued safety concerns at Mission Hospital; sustained negative media about safety can pressure sentiment and invite regulatory/survey scrutiny. Read More.
• Negative Sentiment: Insider selling disclosed: EVP Michael McAlevey sold ~1,694 shares (~$903K). While single insider sales often reflect personal liquidity, markets sometimes view such moves as a minor negative signal. Read More.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $532.98 on Friday. The company has a market capitalization of $119.19 billion, a price-to-earnings ratio of 18.78, a P/E/G ratio of 1.62 and a beta of 1.36. The business’s 50-day moving average is $488.01 and its 200-day moving average is $454.46. HCA Healthcare, Inc. has a 1 year low of $295.00 and a 1 year high of $552.90.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. During the same quarter in the previous year, the company earned $6.22 EPS. HCA Healthcare’s quarterly revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.15%.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the sale, the executive vice president directly owned 8,853 shares of the company’s stock, valued at $4,721,924.61. The trade was a 16.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 15,214 shares of company stock valued at $7,797,595 in the last three months. 1.30% of the stock is owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.